Skip to main content

Animations

Amy Hauck Newman, PhD

Senior Investigator and Chief, Medicinal Chemistry Section at National Institute on Drug Abuse - Intramural Research Program

Dr. Newman received her PhD in Medicinal Chemistry from the Medical College of Virginia, Virginia Commonwealth University, where she designed, synthesized and behaviorally evaluated novel analogues of amphetamine.  She did her post-doctoral training with Dr. Kenner Rice at NIDDK, extending her experience with opiate total synthesis, development of the PET ligand (+)-[18F]cyclofoxy, as well as novel peripheral type benzodiazepine receptor ligands.  After a short tenure at Walter Reed Army Institute of Research, she initiated a Medicinal Chemistry Program at the NIDA-Intramural Research Program. She has focused her research efforts on the design and synthesis of novel molecular tools to elucidate drug-receptor interactions in the brain that ultimately affect behavior. Dr. Newman is currently studying the roles of the dopamine and serotonin transport systems, the dopamine D2 receptor family (D2/D3) and mGluR5, in addiction, with the aim of developing medications for treatment.


Associated Grants

  • Dopamine D1-D3 Receptor Heteromer as a New Target for Parkinson's Disease

    2010


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.